PerkinElmer, Inc. announced late Thursday that it has signed a definitive agreement with Evotec AG to acquire its majority-owned subsidiary, Evotec Technologies GmbH.
Based in Hamburg, Germany, Evotec Technologies is a provider of high performance screening instrumentation and analysis software.
The cash transaction is valued at approximately $30 million and is subject to regulatory approvals and other customary closing conditions. The transaction is targeted for completion in the first quarter of 2007.
Through this acquisition, PerkinElmer will provide its customers in the pharmaceutical, biotechnology and academic arenas with Evotec Technologies’ high content screening (HCS) instruments and software.